Synergistic effect of piperine combined with luteolin on anti-non-small cell lung cancer activity in vitro and in LLC tumour-bearing mice: Mechanistic insights from network pharmacology and molecular docking
Acta Pharmaceutica · 01.06.2026 · 76 (2) · 1-26
DOI: 10.2478/acph-2026-0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, online erschienen am 30.06.2026. Verfasst von Liangfeng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1School of Medicine, Anhui University of Science and Technology, Huainan 232001, China. Hauptthemen laut MEDLINE: Piperidines, Alkaloids, Benzodioxoles, Luteolin. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Piperine had synergistic effects with other natural products in treating lung cancer. The synergistic effects of piperine combined with luteolin on anti-non-small cell lung cancer activity and their mechanism of action are studied using network pharmacology and molecular docking. Cell viability, wound-healing, colony-formation, cell-apoptosis, and cell-cycle tests on A549 cells were used to detect the in vitro synergistic effects. Tumour growth and hematoxylin and eosin (HE) staining were used to verify the synergistic effects in Lewis lung carcinoma (LLC) tumour-bearing mice. Their combination indexes ranged from 0.3 to 0.8 across different concentrations, and the combination of 175.3 µmol L –1 piperine and 87.32 µmol L –1 luteolin showed synergistic inhibition of A549 cell viability. Moreover, the combination induced a higher apoptosis rate (75.60 %) than luteolin (24.56 %) or piperine (17.53 %). It arrested more cells in the G0/G1 phase than luteolin or piperine did. The combination achieved a tumour inhibition rate of 75.28 %, with lower tumour density and more obvious apoptosis. Network pharmacology identified AKT1, EGFR, SRC, and MMP9 as core targets regulating the PI3K/AKT pathway. Multi-software molecular docking confirmed binding of both compounds to these targets, with MMP9 as the common primary target. In conclusion, piperine and luteolin acted synergistically against non-small cell lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1School of Medicine, Anhui University of Science and Technology, Huainan 232001, China.
- 2Key Laboratory of Industrial Dust Deep Reduction and Occupational Health and Safety of Anhui Higher Education Institutes, Huainan 232001, China.
- 3Anhui Province Engineering Laboratory of Occupational Health and Safety Huainan, Anhui Province Engineering Laboratory of Occupational Health and Safety Huainan232001 China.
- 4Key Laboratory of Tropical Medicinal Plant Chemistry of Hainan Province Hainan Normal University, Haikou 570100, China.
- 5Analytical and testing center Anhui University of Science and Technology, Huainan232001, China.
ORCID-Profile: Yuexing Chang
Zitieren
APA
Wang, L., Chang, Y., Liu, Y., Guo, A., Wang, B., Jin, F., & Deng, Y. (2026). Synergistic effect of piperine combined with luteolin on anti-non-small cell lung cancer activity in vitro and in LLC tumour-bearing mice: Mechanistic insights from network pharmacology and molecular docking. Acta Pharmaceutica, 76(2), 1-26. https://doi.org/10.2478/acph-2026-0015
Vancouver
Wang L, Chang Y, Liu Y, Guo A, Wang B, Jin F, et al. Synergistic effect of piperine combined with luteolin on anti-non-small cell lung cancer activity in vitro and in LLC tumour-bearing mice: Mechanistic insights from network pharmacology and molecular docking. Acta Pharmaceutica. 2026;76(2):1-26. doi:10.2478/acph-2026-0015
BibTeX
@article{Wang2026,
author = {Wang, Liangfeng and Chang, Yuexing and Liu, Yufeng and Guo, Ailing and Wang, Baorong and Jin, Feng and Deng, Yun},
title = {Synergistic effect of piperine combined with luteolin on anti-non-small cell lung cancer activity in vitro and in LLC tumour-bearing mice: Mechanistic insights from network pharmacology and molecular docking},
journal = {Acta Pharmaceutica},
year = {2026},
volume = {76},
number = {2},
pages = {1--26},
doi = {10.2478/acph-2026-0015}
}
EUVIMED